first described vitreous bleeding occurring with subarachnoid hemorrhage (SAH). The observation of vitreous hemorrhage in conjunction with any form of intracranial bleeding was named after Albert Terson. 35 The definition has been expanded by some authors to include intraretinal hemorrhage. 5 Espinasse-Berrod and associates 10 suggested that rapid increases in intracranial pressure (ICP) cause decreased venous drainage of the eyes' posterior compartments because of venous congestion. This may result in vitreous hypertension and retinal or vitreous hemorrhage.
The purpose of the present study was to elucidate whether this hypothesis can be supported by ICP measurement and whether Terson's syndrome occurs with similar frequency when caused by severe brain injury accompanied by acutely raised ICP.
Clinical Material and Methods

Patient Population
Twenty-two patients, aged 29 to 80 years, suffering from intracranial hypertension as a consequence of SAH or severe brain injury, were admitted to our institution and entered into the study in 1994. Acute intracranial hypertension was defined as ICP initially exceeding 20 mm Hg, as observed during ventricle catheter implantation or during the first ICP measurements in the intensive care unit (ICU). Thirteen patients with SAH were assigned Grades II to IV according to the scale of the World Federation of Neurological Surgeons 9 and 2 to 4 according to Fisher grading on CT scanning. 11 The nine patients with severe brain injury had initial Glasgow Coma Scale 34 scores of 3 to 10. Intracranial diagnosis and staging were established by the injuries' appearance on CT scanning. All patients with impaired consciousness and/or in whom hydrocephalus was identified on CT scanning underwent ICP monitoring (intraventricular catheter system; Hanni Set, pvb Medizintechnik, Kirchseeon, Germany). The course of the ICP was recorded under steady conditions in the ICU for at least 3 days. All patients entered into the study were examined by indirect ophthalmoscopy without induced mydriasis 17, 27 within the 1st week after the acute event. Visual acuity and other function tests could not be performed because most patients were in a coma. Ophthalmological follow-up examinations at 3 months could be performed in two surviving patients with Terson's syndrome; the other two surviving patients were lost to follow up.
Statistical Analysis
All values are given as means Ϯ standard deviation. Statistical analysis was performed using the WhitneyMann-Wilcoxon test. A significant difference was assumed with an error probability of less than 0.05.
Results
There was no significant difference in maximum, initial, and average ICP within the first 72 hours in patients with SAH (mean maximum ICP 27 Ϯ 9.6 mm Hg; mean initial ICP 17 Ϯ 8. Terson's syndrome ( Fig. 1 ) was observed in 10 (45%) of 22 patients. Six (46%) of 13 patients with SAH and four (44%) of nine patients with severe brain injury (44%) had retinal or vitreous hemorrhage. Ocular bleeding was found bilaterally in three cases of SAH and in one case of severe brain injury (18%). There was no correlation between the severity of the intracerebral pathological conditions graded on CT scans and the amount of intraocular hemorrhage.
With one exception, initial coma was observed in all patients with intraocular hemorrhage. Seven patients with ocular findings showed extremely raised ICP (Ͼ 30 mm Hg) during ventricle catheter placement. The initial ICP values measured in the ICU and the maximum measured ICP values were significantly higher in patients with Terson's syndrome (mean initial ICP 26 Ϯ 6.9 mm Hg in patients with intraocular hemorrhage compared with 15 Ϯ 5.8 mm Hg in others; mean maximum ICP 32 Ϯ 15.5 mm Hg in patients with intraocular hemorrhage compared with 28 Ϯ 11.5 mm Hg in others; mean average ICP 16.5 Ϯ 11.3 mm Hg in patients with intraocular hemorrhage compared with 13 Ϯ 7.3 mm Hg in others; Fig. 2) .
The outcome of patients with intraocular bleeding was poor. Six of 10 patients died within the 3-month follow-up period. One surviving patient with SAH still had not regained vision in one eye at that time because of severe nonclearing vitreous hemorrhage. This patient later underwent pars plana vitrectomy and vision improved to 0.8 within the following weeks. The patient with brain injury who was available for follow-up review showed no visual deterioration.
Discussion
The occurrence of bleeding in posterior eye compartments is a known complication in patients surviving SAH. The reported frequency of Terson's syndrome in such patients ranges between 20% and 50%, 25, 26, 30, 33 which is in accordance with our results. However, this phenomenon has only rarely been described in association with subdural and epidural hematomas or traumatic SAH. 10, 21, 32, 36, 38 Only case reports are found in the literature. Billotte, et al., 4 described Terson's syndrome in an infant with severe brain injury. Another patient was reported to have intracerebral hemorrhage caused by coagulopathy as a consequence of acute promyelocytic leukemia after retinoic acid treatment. 1 Our results suggest that intraocular hemorrhage occurs with similar incidence when caused by severe brain injury compared with SAH and may be responsible for vision impairment in such patients.
Coincident injury to the optic nerve and optic pathways can be found in many cases of severe brain injury.
2,20 Thus, we cannot rule out that intraocular hemorrhage in these patients may have been a condition merely associated with more profound damage to the optic system. Unfortunately, afferent pupillary testing, which might have provided the respective information, was not performed in our study. On the other hand, the available literature on Terson's syndrome does not provide evidence for injury to afferent pathways in cases of severe SAH. Although literature on the topic is sparse, Karel and Gergelyova 18 reported on seven patients with SAH and Terson's syndrome. All underwent pars plana vitrectomy. In six of their patients, vision recovered to values between 0.7 and 1. In the only patient with severe brain injury who was available for follow-up review in our study, no impairment of vision was noted. In another patient with SAH, vision was only restored after pars plana vitrectomy had been performed.
Initial attempts at explaining Terson's syndrome suggested that, in SAH, blood traverses the subarachnoid space into its continuation within the optic nerve sheath. It was thought that blood penetrates the sclera in the porous region where the optic nerve enters the globe, and finally appears in the vitreous space within the eye. 8 Many textbooks still attribute Terson's syndrome to this mechanism, despite evidence that there is no connection between the optic nerve sheath subarachnoid space and the vitreous body.
2, 3 Castren 5 suggested that rapid increases in ICP result in Terson's syndrome, which is caused by venous congestion due to impairment of venous drainage to the cavernous sinus. 10, 12, 16 Retinochoroidal connections and the central retinal vein could be compressed by pressureinduced dilation of the optic nerve-sheath subarachnoid space. 24, 36 Increased venous pressure results in stasis followed by vessel rupture and intraocular hemorrhage. Our own observations support the concept that ICP represents the principal impetus for the development of intraocular hemorrhage because intraocular hemorrhage was associated with higher initial levels of ICP. However, our measurements can only be taken as an indicator of the actual intracranial pressure present when intraocular hemorrhage developed.
In the initial phase of SAH, dramatic increases in ICP are noted for several minutes.
14,15 Such a pressure pattern can also be observed in severe brain injury initially caused by hypercarbia in the unconscious patient. 23 Furthermore, posttraumatic Terson's syndrome may result from plateau waves, which are well described in the early posttraumatic phase. Other patterns of intracranial hypertension without extreme ICP peaks, which are observed, for instance, in hydrocephalus, cavernous sinus thrombosis, or carotid cavernous sinus fistula, do not result in Terson's syndrome. A typical ophthalmological finding in such patients is papilledema but not intraocular hemorrhage.
The outcome of patients with Terson's syndrome has been reported to be poor. In many series the overall mortality rate is significantly higher than that for patients without Terson's syndrome. Garfinkle and colleagues 13 reported a 36.3% mortality rate in patients with intraocular hemorrhage; Pfausler, et al., 28 reported death in nine of 10 patients. In our study we observed a mortality rate of 60%.
The prognosis for vision recovery in surviving patients with SAH has been reported to be good. 32, 36 clearing vitreous hemorrhage may result in blindness. 7, 13, 25 In cases in which there is no tendency for blood resorption, the method of choice is a pars plana vitrectomy. 18 Most authors recommend a period of 6 months after the acute event for the timing of surgery. 19 If vitrectomy is performed, complete recovery of vision can be expected in many cases. 6, 19, 26, 31, 37 Alternatively, intravitreous injections of anti-Rh serum have been reported to improve visual acuity within 5 to 6 weeks in cases of vitreous hemorrhage without proliferative vitreoretinopathy. 29 Nevertheless, all patients should be closely monitored for sequelae of intraocular bleeding. These include the development of intraocular hypertension and retinal membrane formation with resulting retinal detachment. 19, 26 With regard to our own observations, multiple intracranial pathological conditions accompanied by acutely raised ICP may result in intraocular hemorrhage. The frequencies were similar in patients who had severe brain injury compared with those who had SAH. For surviving patients, close ophthalmological evaluation and treatment are recommended.
